Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds-Reference-Cited by-同舟云学术

Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds

Published:2018-07-23 Issue:12 Volume:39 Page:1902-1912
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Gong Grace Qun,Wang Ke,Dai Xin-Chuan,Zhou Yan,Basnet Rajesh,Chen Yi,Yang De-Hua,Lee Woo-Jeong,Buchanan Christina Maree,Flanagan Jack Urquhart,Shepherd Peter Robin,Chen Ying,Wang Ming-Wei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-018-0087-6.pdf

Reference38 articles.

1. Bruhn MA, Pearson RB, Hannan RD, Sheppard KE. AKT-independent PI3-K signaling in cancer-emerging role for SGK3. Cancer Manag Res. 2013;5:281–92.

2. Bruhn MA, Pearson RB, Hannan RD, Sheppard KE. Second AKT: the rise of SGK in cancer signalling. Growth Factors. 2010;28:394–408.

3. Kobayashi T, Cohen P. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J. 1999;339:319–28.

4. Kobayashi T, Deak M, Morrice N, Cohen P. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase. Biochem J. 1999;344:189–97.

5. Xing Y, Liu D, Zhang R, Joachimiak A, Songyang Z, Xu W. Structural basis of membrane targeting by the Phox homology domain of cytokine-independent survival kinase (CISK-PX). J Biol Chem. 2004;279:30662–9.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1;Molecular Diversity;2024-08-09

2. SGK3 overexpression correlates with a poor prognosis in endoscopically resected superficial esophageal squamous cell neoplasia: A long-term study;World Journal of Gastroenterology;2023-06-21

3. An overview of PROTACs: a promising drug discovery paradigm;Molecular Biomedicine;2022-12-20

4. VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives;European Journal of Medicinal Chemistry;2022-01

5. Identification and Kinetic Characterization of Serum- and Glucocorticoid-Regulated Kinase Inhibitors Using a Fluorescence Polarization–Based Assay;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2021-03-30